Amicus Therapeutics Inc (FOLD) and Cerner Corporation (CERN) Look Strong. Which Is The Better Investment At This Time?

Posted by Saimoon March 20, 2015 0 Comment 1017 views


New York, NY – GDP INSIDER  –  03/20/2015.

This article discusses two companies: Amicus Therapeutics Inc (NASDAQ:FOLD) and Cerner Corporation (NASDAQ:CERN)

Amicus Therapeutics Inc (NASDAQ:FOLD) enjoyed strong support with the stock skyrocketing 33.26% or $3.11 to close at $12.46 on extremely high trading of 21.636 million shares, compared to its three month average trading volume of 1.468 million. The biopharmaceutical company specialized in small molecule treatments for rare diseases began to rally after it announced that it had completed a very positive meeting with the European regulators, regarding approval of its treatment for Fabry disease which could move forward its MAA submission for full approval of the treatment to the middle of this year. This comes on the back of U.S. regulators indicating that it could receive accelerated approval for domestic as well. The rally yesterday has pushed the RSI up to 83.64 and created a sharp bullish MACD divergence which may indicate that the stock is heading for a new higher trading range, making it a strong hold with a view to buy.

Do Yesterdays Gains Pose Any Danger To Amicus Therapeutics Inc? Take A Closer Look With Free FOLD Analysis.

Cerner Corporation (NASDAQ:CERN) gained 3.04% or $2.18 yesterday to close at $73.82 with more than 2.946 million shares changing hands, compared to its three month average trading volume of 1.423 million. The designer and developer of hardware and content solutions for health care organizations posted the gains after it announced that is implementing iCentra, an electronic health practice management system, across northern Utah which will act as a model to promote sales to other health regions throughout the country. Cerner Corporation has been charging ahead recently with the stock already up 12.69% so far this year, far outperforming the S&P 500 which has only increased by 1.48% for the same period. With a bullish MACD crossover imminent and RSI of 66.34 there is still room for the stock to continue to climb, provided the results in Utah go as expected. This makes the stock a strong hold and potential buy.

Are The Technical Indicators Supporting Further Gains In Cerner Corporation? Find Out From Our Free CERN Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment